亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Doxepin in the Treatment of Primary Insomnia

多塞平 耐受性 失眠症 安慰剂 原发性失眠 医学 麻醉 内科学 睡眠障碍 睡眠(系统调用) 就寝时间 双盲 精神科 不利影响 替代医学 病理
作者
Göran Hajak,Andrea Rodenbeck,Ulrich Voderholzer,Dieter Wilhelm Riemann,Stefan Cohrs,Fritz Hohagen,Thomas Berger,Eckart Rüther
出处
期刊:The Journal of Clinical Psychiatry [Physicians Postgraduate Press, Inc.]
卷期号:62 (6): 453-463 被引量:199
标识
DOI:10.4088/jcp.v62n0609
摘要

BACKGROUND: Over recent years, the use of antidepressants for the symptomatic treatment of insomnia has grown substantially, but controlled studies are still lacking. Our study is the first investigation to prove objective efficacy and tolerability of low doses of a sedating antidepressant in a randomized, double-blind, and placebo-controlled manner in patients with primary insomnia. METHOD: Forty-seven drug-free patients meeting DSM-IV criteria for primary insomnia (mean +/- SD duration of complaints = 11.2+/-9.7 years) received either 25-50 mg of the tricyclic antidepressant doxepin or placebo for 4 weeks followed by 2 weeks of placebo withdrawal. Sleep was measured by polysomnography at baseline and the first night of application, at 4 weeks of treatment and the first to third night of withdrawal, and after 2 weeks of withdrawal. RESULTS: In the doxepin-treated patients who completed the study (N = 20, 47.6+/-11.3), medication significantly increased sleep efficiency after acute (night 1, p < or = .001) and subchronic (night 28, p < or = .05) intake compared with the patients who received placebo (N = 20, 47.4+/-16.8 years of age). Latency to sleep onset was not affected since the patients had normal baseline sleep latencies. Investigators found doxepin to cause significantly (p < or = .05) better global improvement at the first day of treatment. Patients rated sleep quality (p < or = .001) and working ability (p < or = .005) to be significantly improved by doxepin during the whole treatment period. Overall rebound in sleep parameters was not observed, but patients with severe rebound insomnia were significantly more frequent in the doxepin group (night 29, p < .01, night 30, p < or = .01; night 31, p < or = .05). No significant group differences in side effects were found, but 2 doxepin-treated patients dropped out of the study due to specific side effects (increased liver enzymes, leukopenia, and thrombopenia). CONCLUSION: The results support the effectiveness of low doses of doxepin to improve sleep and working ability in chronic primary insomniacs, although subjective effects were light to moderate, and in some patients, rebound insomnia and specific side effects have to be considered.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
10秒前
Ccccn完成签到,获得积分10
15秒前
Voiceless发布了新的文献求助10
18秒前
19秒前
满意的平凡完成签到,获得积分10
24秒前
伶俐的秀发完成签到,获得积分10
25秒前
ChenYQ完成签到,获得积分10
51秒前
苹果完成签到 ,获得积分10
58秒前
殷勤的半凡完成签到,获得积分10
1分钟前
耍酷的手套完成签到,获得积分10
1分钟前
1分钟前
1分钟前
充电宝的应助被爱学习的doge采纳,获得10
1分钟前
1分钟前
1分钟前
1分钟前
orixero的应助被爱学习的doge采纳,获得10
1分钟前
隐形曼青的应助被爱学习的doge采纳,获得10
1分钟前
在水一方的应助被爱学习的doge采纳,获得10
1分钟前
大模型的应助被爱学习的doge采纳,获得10
1分钟前
华仔的应助被爱学习的doge采纳,获得10
1分钟前
香蕉觅云的应助被爱学习的doge采纳,获得10
1分钟前
CodeCraft的应助被爱学习的doge采纳,获得10
1分钟前
SciGPT的应助被爱学习的doge采纳,获得10
1分钟前
隐形曼青的应助被爱学习的doge采纳,获得10
1分钟前
小二郎的应助被爱学习的doge采纳,获得10
1分钟前
852的应助被爱学习的doge采纳,获得10
1分钟前
1分钟前
田様的应助被爱学习的doge采纳,获得10
1分钟前
脑洞疼的应助被爱学习的doge采纳,获得10
1分钟前
bkagyin的应助被爱学习的doge采纳,获得10
1分钟前
顺利水桃完成签到,获得积分10
1分钟前
1分钟前
乐乐的应助被mengdewen采纳,获得10
1分钟前
1分钟前
1分钟前
1分钟前
1分钟前
1分钟前
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8179924
求助须知:如何正确求助?哪些是违规求助? 9570159
关于积分的说明 21808379
捐赠科研通 7775767
什么是DOI,文献DOI怎么找? 3433193
关于科研通互助平台的介绍 2557347
邀请新用户注册赠送积分活动 2478918